U City Public Company Limited (Registration No. 0107537000459) 21 TST Tower Soi Choei Phuang, Viphavadi-Rangsit Road, Chomphon, Chatuchak, Bangkok 10900, Thailand T: + 662 273 8838 F: + 662 273 8858 www.ucity.co.th Ref. No. U.SET 019/2017 October 30, 2017 Subject: Entire business transfer of Unicorn Enterprise Company Limited, capital increase, issuance of the U-W3 Warrants and U-W4 Warrants, issuance and offering of the newly issued preferred shares to be issued and offered to the existing shar...
prepared. DNAL Co., Ltd.’s financial statements for the period ended June 30, 2017 are disclosed herein as a comparative statement. Unit: Baht million Separate Financial Statements Fiscal Year Quarter March
proportion than selling price increase is the main reason why net profit decrease. Graphite Electrode’s price which is a part of conversion cost increase significantly. Separate financial statement, the
significantly, and net loss from exchange rate. Separate financial statement, the Company posted net loss Baht 1,056 million comparing with previous quarter which has net profit Baht 119 million. Total revenue
increase however raw material cost and cash conversion cost also high, therefore, result in net loss. Separate financial statement, the Company has net loss Baht 192 million, decreased in net loss comparing
aforementioned electricity fee since December 2011. According to Separate Financial Statements of the Company as at 30 September 2017, the Company has total liabilities of THB 17,622 million, which can be
types of securities to support strategic fund mobilization and accommodate new product launches; (4) To divide intermediary supervisory units with separate focuses on development and inspection; (5
exchange rate increased of Baht 6.75 million. The separate operating result for the year ended December 31, 2017 The Company had net income of Baht 14.55 million comparing to the same period of the previous
Financial performances Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% Q1/2019 Q1/2018 Q1/2018 Q1/2017 Revenues from sales and services of medical equipment 460,711 366,698 26% 382,283 320,648
Company Limited (“the Company”) would like to report on Management Discussion and Analysis from the Separate and Consolidated Financial Statements of the 1st quarter ended March 31, 2018. The details are as